U.S. Food and Drug Administration Clears the UPnRIDE™ Standing Wheelchair for Distribution in America

• World’s First Smart Robotic Wheelchair UPnRIDE^™ Receives FDA Clearance
• UPnRIDE^™ Founder & President to Speak at AIPAC Policy Conference

WATCH UPnRIDE^™ TESTIMONIALS HERE

PHOTOS HERE

YOKNEAM, Israel--(BUSINESS WIRE)-- UPnRIDE Robotics Ltd. announced today that the U.S. Food and Drug Administration (FDA) has cleared the UPnRIDE^™ Robotic Standing Wheelchair for marketing and use in the U.S. This first and only smart and robotic mobility device provides full functionality, both in standing and sitting positions. The UPnRIDE^TM will be available soon for wheelchair users and the elderly in the U.S.

“The approval of our UPnRIDE™ standing wheelchair is another very important milestone in our mission to offer health benefits and improved quality of life to millions of people suffering from walking impairments,” said Dr. Amit Goffer, founder and president of UPnRIDE^™ Robotics Ltd.

Commenting on the FDA clearance, Dr. Goffer added: “I have had a long-standing vision that all people confined to a wheelchair should have access to enhanced mobility and enjoy the many health benefits associated with the ability to perform everyday tasks in a standing position. With the introduction of UPnRIDE^TM, this dream is becoming a reality.”

The UPnRIDE^TM standing wheelchair is innovative and unique in providing users with full, safe, functional mobility in a standing position, in practically any urban environment, both indoors and outdoors. The UPnRIDE^TM mobility device is suitable for most wheelchair users, including paraplegics, quadriplegics, the elderly and people suffering from MS, ALS, CP, stroke, TBI and other conditions that limit physical movement.

“Empowered by the FDA approval, UPnRIDE^™ Robotics will now develop a distribution and service center network in the U.S. to enable American users to benefit from this innovative product,” said Oren Tamari, CEO of UPnRIDE^™ Robotics Ltd.

“By enabling upright mobility, UPnRIDE^TM delivers numerous health, economic and societal benefits. It reduces the visibility of the disability, providing wheelchair users with a fresh, new perspective on the world, on themselves, and on life,” Tamari added.

Dr. Goffer, who is himself a quadriplegic is an entrepreneur and the father of ReWalk, the wearable robotic exoskeleton that enables people with spinal cord injury to stand upright and walk. He is scheduled to speak in front of 18,000 people this Sunday at the AIPAC Policy Conference, where he promised his audience seven years ago that he would return on stage upright. On Sunday, he will fulfill that promise. UPnRIDE^TM originated from the commitment Dr. Goffer made to himself to allow paraplegics to walk again, as he personally needed a solution to take wheelchairs into the 21st century.

To interview Dr. Amit Goffer at the 2020 AIPAC Policy Conference, contact Oren Tamari at oren@upnride.com / +972-4-6110061 or Dr. Amit Gofer at amit@upnride.com / 972-52-230411.

About UPnRIDE^™ Robotics Ltd.: UPnRIDE^™ RIDE Robotics Ltd. is a developer of innovative life-changing upright mobility and assistive technologies, intended for the disabled and elderly people, and has spurred a significant leap forward in this field. The company plans to develop a variety of products, the first of which is the UPnRIDE^TM - a revolutionary smart and robotic wheeled mobility device allowing wheelchair users to be fully mobile in both standing and sitting positions, in practically any urban environment. For more information visit: https://upnride.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20200227005438/en/